MeSH tree: N04.761
Results of the Phase III COMPETE clinical trial show that the targeted radiotherapeutic agent [177Lu]Lu-edotreotide significantly prolonged progression-free survival in patients with metastatic gastroenteropancreatic neuroendocrine ...
16 hours ago
0
3
For patients with clear-cell renal cell carcinoma, pembrolizumab-belzutifan yields significantly higher disease-free survival, according to a study published in the July 2 issue of the New England Journal of Medicine.
Jul 6, 2026
0
2
A 10-year national study has found improved antimicrobial use in Australian hospitals that regularly monitored their prescribing, using a globally unique program developed by a Melbourne hospital. The study reinforces the ...
Jul 3, 2026
0
3
For patients with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL), adding pirtobrutinib to venetoclax-rituximab (PVR) yields improved progression-free survival (PFS) compared to venetoclax-rituximab (VR), according ...
Jul 2, 2026
0
3
Results of the ongoing eNRGy trial, a single-arm, multicenter, global Phase II clinical trial evaluating zenocutuzumab in solid tumors positive for Neuregulin 1 (NRG1) gene fusions, reported manageable side effects and clinically ...
Jul 1, 2026
0
4
A large real-world clinical trial has found that a generative AI-powered support tool used to support frontline clinicians was safe and improved the quality of clinical decision-making, but did not significantly change short-term ...
Jun 26, 2026
0
6
Hourly movement breaks of just five minutes each seem to offer the best balance between feasibility and effectiveness for mitigating the health harms of prolonged sitting, suggests a large study carried out under real-world ...
Jun 23, 2026
0
4
Global health policymakers should focus on the way entire health care systems work together, argue researchers in new findings. Improving one element does not always create better outcomes if the wider system is not ready.
Jun 21, 2026
0
3
The U.S. Food and Drug Administration has approved Merck's Welireg (belzutifan) in combination with pembrolizumab or pembrolizumab and berahyaluronidase alfa-pmph (Keytruda Qlex) for the adjuvant treatment of renal cell carcinoma ...
Jun 19, 2026
0
8
Physicians and researchers at the Netherlands Cancer Institute have developed an AI model that outperforms physicians in evaluating treatment response in pleural mesothelioma. Far more accurate than the current international ...
Jun 17, 2026
0
4
